HK1001286A1 - Benzopyrans and their use as therapeutic agents. - Google Patents

Benzopyrans and their use as therapeutic agents.

Info

Publication number
HK1001286A1
HK1001286A1 HK98100154A HK98100154A HK1001286A1 HK 1001286 A1 HK1001286 A1 HK 1001286A1 HK 98100154 A HK98100154 A HK 98100154A HK 98100154 A HK98100154 A HK 98100154A HK 1001286 A1 HK1001286 A1 HK 1001286A1
Authority
HK
Hong Kong
Prior art keywords
benzopyrans
therapeutic agents
therapeutic
agents
Prior art date
Application number
HK98100154A
Other languages
English (en)
Inventor
Wai Ngor Chan
Helen Kate Ann Morgan
Mervyn Thompson
John Morris Evans
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9411632A external-priority patent/GB9411632D0/en
Priority claimed from GB9411798A external-priority patent/GB9411798D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1001286A1 publication Critical patent/HK1001286A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
HK98100154A 1994-06-10 1998-01-08 Benzopyrans and their use as therapeutic agents. HK1001286A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9411632A GB9411632D0 (en) 1994-06-10 1994-06-10 Novel treatment
GB9411798A GB9411798D0 (en) 1994-06-13 1994-06-13 Novel treatment
PCT/EP1995/002076 WO1995034545A1 (en) 1994-06-10 1995-05-31 Benzopyrans and their use as therapeutic agents

Publications (1)

Publication Number Publication Date
HK1001286A1 true HK1001286A1 (en) 1998-06-12

Family

ID=26305044

Family Applications (2)

Application Number Title Priority Date Filing Date
HK98100154A HK1001286A1 (en) 1994-06-10 1998-01-08 Benzopyrans and their use as therapeutic agents.
HK02100192.4A HK1039115B (zh) 1994-06-10 2002-01-10 苯並吡喃和牠們作為治療劑的使用法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK02100192.4A HK1039115B (zh) 1994-06-10 2002-01-10 苯並吡喃和牠們作為治療劑的使用法

Country Status (29)

Country Link
US (1) US5760074A (pt)
EP (2) EP0764157B1 (pt)
JP (2) JP3575767B2 (pt)
KR (1) KR100397721B1 (pt)
CN (2) CN1234702C (pt)
AP (1) AP714A (pt)
AT (2) ATE211469T1 (pt)
AU (1) AU701060B2 (pt)
BG (1) BG63339B1 (pt)
BR (1) BR9507980A (pt)
CA (1) CA2192480C (pt)
CY (1) CY2508B1 (pt)
CZ (1) CZ286081B6 (pt)
DE (2) DE69524871T2 (pt)
DK (2) DK0764157T3 (pt)
ES (2) ES2207590T3 (pt)
FI (1) FI120686B (pt)
HK (2) HK1001286A1 (pt)
HU (1) HUT76136A (pt)
NO (1) NO315651B1 (pt)
NZ (1) NZ287872A (pt)
OA (1) OA10593A (pt)
PL (1) PL188134B1 (pt)
PT (2) PT1114821E (pt)
RO (1) RO113463B1 (pt)
SG (1) SG67930A1 (pt)
SI (2) SI0764157T1 (pt)
SK (1) SK281456B6 (pt)
WO (1) WO1995034545A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010021780A1 (en) * 1992-12-11 2001-09-13 Smithkline Beecham P.L.C. Pharmaceutical composition containing bicyclic type compounds
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment
US6492415B2 (en) * 1996-09-18 2002-12-10 Smithkline Beecham P.L.C. Use of benzopyranols to treat neurological disorders
GB9619492D0 (en) * 1996-09-18 1996-10-30 Smithkline Beecham Plc Novel treatment
GB9726543D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel compositions
GB9813949D0 (en) * 1998-06-29 1998-08-26 Smithkline Beecham Plc Novel compounds
GB0028697D0 (en) * 2000-11-23 2001-01-10 S P A Novel process
BRPI0607684A2 (pt) * 2005-04-04 2009-09-22 Takeda Pharmaceutical composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida
EP2296646A2 (en) * 2008-06-05 2011-03-23 Minster Research Limited Novel treatments
MX2010013313A (es) * 2008-06-05 2011-05-30 Minster Res Ltd Tratamientos novedosos.
CN102970991A (zh) * 2009-12-03 2013-03-13 普罗克西梅根有限公司 异常性疼痛和痛觉增敏的治疗
MX2012006353A (es) 2009-12-03 2012-06-27 Proximagen Ltd Tratamiento de enfermedades infecciosas.
AU2013285164A1 (en) 2012-07-03 2015-01-22 Proximagen Limited Pro-drug compounds
GB201304814D0 (en) * 2013-03-15 2013-05-01 Proximagen Ltd Pro-drug compounds
GB201322932D0 (en) * 2013-12-23 2014-02-12 Proximagen Ltd Pro-drug compounds
GB201322934D0 (en) 2013-12-23 2014-02-12 Proximagen Ltd Prodrug compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3479726D1 (de) * 1983-05-18 1989-10-19 Beecham Group Plc Benzopyran derivatives.
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
ATE190055T1 (de) * 1992-12-11 2000-03-15 Smithkline Beecham Plc Pharmazeutische zusammenstellung enthaltende bizyklisch typ verbindungen
WO1994013656A1 (en) * 1992-12-11 1994-06-23 Smithkline Beecham Plc Bicyclic compounds with pharmaceutical activity
US5536718A (en) * 1995-01-17 1996-07-16 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists

Also Published As

Publication number Publication date
WO1995034545A1 (en) 1995-12-21
NZ287872A (en) 1998-05-27
PT764157E (pt) 2002-06-28
BG101040A (en) 1997-08-29
PL317579A1 (en) 1997-04-14
CN1174975C (zh) 2004-11-10
HK1039115B (zh) 2004-08-13
SK281456B6 (sk) 2001-03-12
CA2192480C (en) 2007-07-24
KR100397721B1 (ko) 2004-04-28
JP3575767B2 (ja) 2004-10-13
ATE211469T1 (de) 2002-01-15
SI1114821T1 (en) 2004-02-29
EP0764157B1 (en) 2002-01-02
EP1114821A1 (en) 2001-07-11
CN1154698A (zh) 1997-07-16
JPH10501251A (ja) 1998-02-03
DE69524871D1 (de) 2002-02-07
DE69524871T2 (de) 2002-08-22
DE69531801D1 (de) 2003-10-23
PL188134B1 (pl) 2004-12-31
SI0764157T1 (en) 2002-06-30
EP0764157A1 (en) 1997-03-26
CN1336369A (zh) 2002-02-20
US5760074A (en) 1998-06-02
AP714A (en) 1998-12-23
CZ361796A3 (en) 1997-08-13
FI120686B (fi) 2010-01-29
DE69531801T2 (de) 2004-07-01
AU2672795A (en) 1996-01-05
AU701060B2 (en) 1999-01-21
CA2192480A1 (en) 1995-12-21
SG67930A1 (en) 1999-10-19
NO315651B1 (no) 2003-10-06
RO113463B1 (ro) 1998-07-30
ES2207590T3 (es) 2004-06-01
HU9603415D0 (en) 1997-02-28
BR9507980A (pt) 1997-08-12
DK0764157T3 (da) 2002-04-22
PT1114821E (pt) 2004-02-27
CN1234702C (zh) 2006-01-04
BG63339B1 (bg) 2001-10-31
ES2170798T3 (es) 2002-08-16
SK158796A3 (en) 1997-07-09
CY2508B1 (en) 2005-12-23
CZ286081B6 (cs) 2000-01-12
NO965260L (no) 1997-02-06
FI964936A (fi) 1997-02-06
NO965260D0 (no) 1996-12-09
EP1114821B1 (en) 2003-09-17
HUT76136A (en) 1997-06-30
AP9600889A0 (en) 1997-01-31
JP2003238554A (ja) 2003-08-27
DK1114821T3 (da) 2004-02-02
HK1039115A1 (en) 2002-04-12
FI964936A0 (fi) 1996-12-10
OA10593A (en) 2002-07-10
ATE250052T1 (de) 2003-10-15

Similar Documents

Publication Publication Date Title
CY2508B1 (en) Benzopyrans and their use as therapeutic agents
ZA9711029B (en) Therapeutic agents.
GB9402641D0 (en) Therapeutic agents
ZA935575B (en) Therapeutic agent and its use.
GB9410031D0 (en) Therapeutic agents
GB9411955D0 (en) Therapeutic agents
GB9409264D0 (en) Therapeutic agents
GB9415575D0 (en) Therapeutic agents
GB9319772D0 (en) Therapeutic agent
GB9401879D0 (en) Therapeutic agents
GB9403639D0 (en) Therapeutic agents
ZA954732B (en) Benzopyrans and their use as therapeutic agents
ZA975418B (en) Spiro-piperidine derivatives and their use as therapeutic agents.
GB9406278D0 (en) Therapeutic agent
ZW1194A1 (en) Therapeutic agent
ZA991021B (en) Benzofuran-4-carboxamides and their therapeutic use.
GB9402011D0 (en) Therapeutic agents
GB9403072D0 (en) Therapeutic agents
GB9402017D0 (en) Therapeutic agents
GB9404540D0 (en) Therapeutic agents
GB9407032D0 (en) Therapeutic agents
GB9407189D0 (en) Therapeutic agents
GB9425839D0 (en) Therapeutic agents
GB9415576D0 (en) Therapeutic agents
GB9401639D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
CORR Corrigendum

Free format text: CORRECTED DATA OF SECTION 27 TO JOURNAL OF 20050722: [54] BENZOPYRANS AND THEIR USE AS THERAPEUTIC AGENTS; [73] SMITHKLINE BEECHAM PLC, NEW HORIZONS COURT, BRENTFORD, MIDDLESEX TW8 9EP, - UNITED KINGDOM; [72] WAI NGOR CHAN W N - HELEN KATE ANN MORGAN H K A - MERVYN THOMPSON M - JOHN MORRIS EVANS J M

PE Patent expired

Effective date: 20150530